Howard Hughes (NYSE: HHH) director receives 2,169-share restricted stock award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Wautier Jean-Baptiste Robert Bernard reported acquisition or exercise transactions in this Form 4 filing.
Howard Hughes Holdings Inc. director Jean-Baptiste Robert Bernard Wautier received a grant of 2,169 shares of common stock as restricted stock compensation. The award was made at no cash cost to him under the company’s 2025 Equity Incentive Plan.
These restricted shares vest on the earlier of the company’s 2027 annual stockholders meeting or June 1, 2027. Following this grant, Wautier holds a total of 4,263 shares of Howard Hughes Holdings common stock directly, reflecting routine equity-based director compensation rather than an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Wautier Jean-Baptiste Robert Bernard
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common stock, $0.01 par value | 2,169 | $0.00 | -- |
Holdings After Transaction:
Common stock, $0.01 par value — 4,263 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Restricted stock grant: 2,169 shares
Post-grant holdings: 4,263 shares
Grant price: $0.00 per share
+1 more
4 metrics
Restricted stock grant
2,169 shares
Common stock award on June 19, 2026
Post-grant holdings
4,263 shares
Total direct common stock after transaction
Grant price
$0.00 per share
Reported transaction price for restricted stock
Vesting deadline
June 1, 2027
Vests earlier of 2027 annual meeting or this date
Key Terms
restricted stock, 2025 Equity Incentive Plan, non-employee directors, vest
4 terms
restricted stock financial
"Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
2025 Equity Incentive Plan financial
"Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan."
non-employee directors financial
"Represents restricted stock granted to non-employee directors pursuant to the Issuer's 2025 Equity Incentive Plan."
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
vest financial
"The shares vest on the earlier of the 2027 annual meeting of stockholders or June 1, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did the Howard Hughes Holdings (HHH) director acquire in this Form 4?
The director received 2,169 shares of Howard Hughes Holdings common stock as a restricted stock grant. This was part of equity compensation, issued at no cash cost, and structured under the company’s 2025 Equity Incentive Plan for non-employee directors.
Was the Howard Hughes (HHH) director grant in this Form 4 an open-market purchase?
No, the transaction was not an open-market purchase. The director received 2,169 restricted shares as a compensation grant at a reported price of $0.00 per share, rather than buying shares on the market, reflecting routine equity-based director compensation.